SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-16-114451
Filing Date
2016-04-27
Accepted
2016-04-27 08:13:13
Documents
3
Period of Report
2016-04-27

Document Format Files

Seq Description Document Type Size
1 6-K a16-9560_16k.htm 6-K 17097
2 EX-99.1 a16-9560_1ex99d1.htm EX-99.1 171860
3 GRAPHIC g95601mm01i001.jpg GRAPHIC 2592
  Complete submission text file 0001104659-16-114451.txt   193637
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37558 | Film No.: 161593456
SIC: 2834 Pharmaceutical Preparations